Sarah Johnson

8PUBLICATIONS
130CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 29, 2025
Mathematical Modeling and Association Analysis Decipher the Impact of the Gut Microbiome on Cancer Immunotherapy.

Andreas G Hadjigeorgiou, Constantinos Harkos, Aditya K Mishra

|Jul 19, 2023
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells.

Yogesh Goyal, Gianna T Busch, Maalavika Pillai

|May 03, 2023
Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance.

Joon Seok Park, Francesca S Gazzaniga, Meng Wu

|Nov 11, 2022
Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration.

Yifan Zhou, Yusra B Medik, Bhakti Patel

|Jun 15, 2022
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.

Christopher P Vellano, Michael G White, Miles C Andrews

|Dec 23, 2021
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.

Christine N Spencer, Jennifer L McQuade, Vancheswaran Gopalakrishnan

Pageof 2

Frequent Collaborators

8 joint publications

Jennifer A Wargo

6 joint publications

Golnaz Morad

4 joint publications

Stephanie S Watowich

4 joint publications

Courtney W Hudgens